ImpressedRetaining the equivalent of a buck in cash for each share is a slick trick, no matter how it was achieved. I'm on record here as bleating that Craig Mull doesn't know what he's doing, but I'd be well beyond happy to be proven wrong -- which might be the case after a few more quarters like this one. Epuris is still in the cross-hairs of competitors. Verity is never anyone's partner of first or even third choice. Cipher still has no presence either in physician offices or on Bay Street. But those are all quibbles. This is a good set of metrics, and I'm well pleased to say so.